MM

Matthew Meyerson

DI Dana-Farber Cancer Institute: 31 patents #13 of 1,343Top 1%
TI The Broad Institute: 15 patents #16 of 760Top 3%
The General Hospital: 9 patents #154 of 3,021Top 6%
BP Bayer Pharma: 8 patents #102 of 819Top 15%
BH Bayer Healthcare: 6 patents #1,523 of 8,007Top 20%
BH Brigham and Women's Hospital: 1 patents #847 of 1,764Top 50%
TI The Board Institute: 1 patents #3 of 27Top 15%
Harvard University: 1 patents #1,740 of 3,600Top 50%
📍 Boston, MA: #167 of 5,993 inventorsTop 3%
🗺 Massachusetts: #2,928 of 88,656 inventorsTop 4%
Overall (All Time): #115,359 of 4,157,543Top 3%
31
Patents All Time

Issued Patents All Time

Showing 26–31 of 31 patents

Patent #TitleCo-InventorsDate
9035036 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments Daphne Winifred Bell, Daniel A. Haber, Pasi Janne, Bruce E. Johnson, Thomas J. Lynch +4 more 2015-05-19
8465916 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments Daphne Winifred Bell, Daniel A. Haber, Pasi Janne, Bruce E. Johnston, Thomas J. Lynch +4 more 2013-06-18
8105769 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments Daphne Winifred Bell, Daniel A. Haber, Pasi Janne, Bruce E. Johnston, Thomas J. Lynch +4 more 2012-01-31
7964349 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments Daphne Winifred Bell, Daniel A. Haber, Pasi Janne, Bruce E. Johnston, Thomas J. Lynch +4 more 2011-06-21
7294468 Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments Daphne Winifred Bell, Daniel A. Haber, Pasi Janne, Bruce E. Johnson, Thomas J. Lynch +4 more 2007-11-13
6996477 Computational subtraction method 2006-02-07